Spire Wealth Management Iveric Bio, Inc. Transaction History

Spire Wealth Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$18.67 - $24.56 $466 - $614	25 New	25 $0
Q2 2022 Jul 22, 2022	SELL	$9.12 - $18.9 $7,295 - $15,119	-800 Reduced 50.0%	800 $8,000
Q1 2022 Apr 18, 2022	SELL	$12.15 - $16.83 $303 - $420	-25 Reduced 1.54%	1,600 $27,000
Q4 2021 Jan 14, 2022	BUY	$13.83 - $18.78 $345 - $469	25 Added 1.56%	1,625 $27,000
Q3 2021 Oct 22, 2021	SELL	$7.07 - $17.5 $11,312 - $28,000	-1,600 Reduced 50.0%	1,600 $26,000
Q2 2021 Jul 26, 2021	SELL	$5.69 - $7.17 $142 - $179	-25 Reduced 0.78%	3,200 $20,000
Q1 2021 May 21, 2021	BUY	$5.08 - $6.89 $16,383 - $22,220	3,225 New	3,225 $20,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.